Tenderwize
Retour à la recherche

Eltrombopag rebate agreement

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 339 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Eltrombopag, ausgeschl. Anwendungsgebiet schwere aplastische Anämie in der Fachinformation, es sei denn, der Hersteller genießt hierfür Patenschutz, ATC B02BX05

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive open-house rebate agreements for the medicinal product Eltrombopag (ATC B02BX05).
  • Exclusion of the severe aplastic anemia indication in the product information, unless the manufacturer has patent protection for that indication.
Afficher le résumé complet

Open-house supply arrangement for pharmaceutical products: non-exclusive rebate agreements for Eltrombopag (ATC B02BX05), excluding the severe aplastic anemia indication unless the manufacturer has patent protection for that indication. The contracting buyer is AOK Bayern. This is explicitly described as a non-competitive open-house model with no selection of one or more bidders; any pharmaceutical company meeting the stated suitability requirement may join on identical, non-negotiable terms. Contracting is possible until 03.08.2027, with monthly start dates depending on when complete documents are received. Procurement documents are available via DTVP, but only the notice text was analyzed, not the full document set.

Risques

The notice explicitly says the contract documents must be submitted via the communication area of the DTVP portal and n...

The final contract-conclusion deadline is 03.08.2027, and monthly cut-offs apply for next-month starts; missing the cut...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Eltrombopag rebate agreement

Open-house rebate agreement for Eltrombopag, excluding the severe aplastic anemia indication in the product information unless the manufacturer has patent protection for that indication. Scope is supplies of pharmaceutical products under a non-exclusive, identical, non-negotiable rebate contract. The lot information comes from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Sep 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Aug 03, 2027

Détails de la procédure

Date de publication
13 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
533121-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30